SBI Securities’s IN8bio INAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$133 Buy
+100
New +$117 ﹤0.01% 3516
2025
Q2
– Sell
-34
Closed -$167 – 4186
2025
Q1
$167 Buy
+34
New +$271 ﹤0.01% 3281
2024
Q4
– Hold
0
– – – 4061

Other funds holding INAB

SBI Securities's INAB Position: Q3 2026 in Review

SBI Securities opened a new position in IN8bio (INAB) in Q3 2026: 100 shares worth $133. The stake represents ﹤0.01% of the portfolio and ranks #3516 among its holdings. This is a return to the name: SBI Securities previously reported a position in INAB as recently as Q1 2025.

SBI Securities first reported a position in INAB in Q1 2025 and has held it in 2 quarters since. The position peaked at $167 in Q1 2025. 3 funds tracked by Wall St. Rank hold INAB as of Q3 2026.

  • SBI Securities held 100 shares of IN8bio worth $133 as of Q3 2026.
  • IN8bio was a new SBI Securities position in Q3 2026.
  • IN8bio made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3516 holding.
  • SBI Securities first reported a position in IN8bio in Q1 2025 and has held it in 2 quarters since.
  • SBI Securities's IN8bio position peaked at $167 in Q1 2025.
  • 3 funds tracked by Wall St. Rank held IN8bio as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.